Adamantyl-THPINACA

Overview

Adamantyl-THPINACA is a synthetic cannabinoid that has been identified in various designer drug products. It is a potent agonist of the cannabinoid receptors, which are part of the endocannabinoid system in the human body. This compound is part of a class of synthetic cannabinoids that are often used as recreational drugs due to their psychoactive effects.

Chemical Structure

Chemical structure of Adamantyl-THPINACA

Adamantyl-THPINACA is characterized by the presence of an adamantyl group, which is a bulky, cage-like structure that can influence the compound's interaction with cannabinoid receptors. The chemical structure of Adamantyl-THPINACA includes a tetrahydropyran ring, which is a common feature in many synthetic cannabinoids.

Pharmacology

Adamantyl-THPINACA acts as a full agonist at the CB1 and CB2 receptors, which are the primary targets of cannabinoids in the body. The activation of these receptors by Adamantyl-THPINACA can lead to a range of effects, including altered perception, mood changes, and impaired motor function. The potency and efficacy of Adamantyl-THPINACA at these receptors are significant, contributing to its psychoactive properties.

Legal Status

The legal status of Adamantyl-THPINACA varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. Regulatory agencies often monitor and update the legal status of synthetic cannabinoids as new compounds are identified and characterized.

Health Effects

The use of Adamantyl-THPINACA, like other synthetic cannabinoids, can pose significant health risks. Adverse effects may include tachycardia, hypertension, nausea, vomiting, and anxiety. In severe cases, use can lead to psychosis, seizures, and renal failure. The variability in potency and purity of synthetic cannabinoid products further complicates the risk profile.

Related Pages

• Synthetic cannabinoids
• Cannabinoid receptor
• Endocannabinoid system
• Designer drug